<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01617759</url>
  </required_header>
  <id_info>
    <org_study_id>Asp-PCR-CSF</org_study_id>
    <nct_id>NCT01617759</nct_id>
  </id_info>
  <brief_title>Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis</brief_title>
  <official_title>Diagnostic Study on the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central nervous system (CNS) invasive aspergillosis (IA) is a fatal complication in
      immunocompromised patients. Confirming the diagnosis is rarely accomplished as invasive
      procedures are hampered by neutropenia and low platelet count. Cerebrospinal fluid (CSF)
      cultures or galactomannan (GM) regularly yield negative results thus suggesting the need for
      improving diagnostics. Therefore the performance of an established Aspergillus-specific
      nested PCR in CSF samples of immunocompromised patients with suspicion of CNS IA will be
      evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Central nervous system (CNS) invasive aspergillosis (IA) is a fatal complication in
      immunocompromised patients with hematological malignancies. Confirming the diagnosis is
      rarely accomplished as invasive procedures are impaired by neutropenia and low platelet
      count. Cerebrospinal fluid (CSF) cultures or galactomannan (GM) regularly yield negative
      results thus suggesting the need for improving diagnostic tools. Therefore the performance of
      an established Aspergillus-specific nested PCR assay in CSF samples of immunocompromised
      patients with suspicion of CNS IA will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Test sensititivity</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aspergillosis</condition>
  <condition>Infection in an Immunocompromised Host</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      fungal DNA from CSF samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Immunocompromised individuals
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Immunocompromised patients with suspected CNS infection, especially cerebral
             aspergillosis

        Exclusion Criteria:

          -  proven CNS infections caused by pathogens other than Aspergillus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dieter Buchheidt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mannheim University Hospital, University of Heidelberg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mannheim University Hospital</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2012</study_first_submitted>
  <study_first_submitted_qc>June 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2012</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Dieter Buchheidt</investigator_full_name>
    <investigator_title>Senior Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspergillosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

